SCHEMBL7477484

SCHEMBL7477484

[2H]CN(C[2H])[C@@H](CCC)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC7 Q8WUI4 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
GRIK1 P39086 1/20 0.38
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
GRIK2 Q13002 1/20 0.38
CHRM1 P11229 1/20 0.38
AKR1A1 P14550 1/20 0.38
CHRM3 P20309 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
DRD3 P35462 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13884916 0.85 HDAC7 (0.43) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL2127724 0.85 HDAC7 (0.43) HDAC7HDAC8HDAC6HDAC9HDAC5
SCHEMBL4594802 0.72 CA2 (0.52) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL4595724 0.72 CA2 (0.52) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL4594560 0.72 CA2 (0.52) GRIK1SLC1A3SLC1A2SLC1A1GRIK2
SCHEMBL12285998 0.71 CA1 (0.45) GRIK1SLC1A2SLC1A1GRIK2CA1
SCHEMBL25389975 0.69 GRIK1 (0.44) GRIK1SLC1A2SLC1A1GRIK2CA1
SCHEMBL28958158 0.69 GRIK1 (0.44) GRIK1SLC1A2SLC1A1GRIK2CA1
SCHEMBL28458244 0.69 GRIK1 (0.44) GRIK1SLC1A2SLC1A1GRIK2CA1
Valpromide SCHEMBL35392 0.69 CA2 (0.58) HDAC7HDAC8HDAC6HDAC9HDAC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP disclosed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP disclosed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed